APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isoxazoline Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Isoxazoline Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025182 pages

Choose your research edition.

Industry ResearchIsoxazoline Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoxazoline Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Isoxazoline Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoxazoline Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoxazoline Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Isoxazoline Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Isoxazoline Drugs include Zoetis Inc, Nissan Chemical Corporation, Merck Animal Health Inc., Elanco Animal Health Incorporated and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Isoxazoline Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isoxazoline Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isoxazoline Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isoxazoline Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Isoxazoline Drugs Segment by Company

Zoetis Inc

Nissan Chemical Corporation

Merck Animal Health Inc.

Elanco Animal Health Incorporated

Boehringer Ingelheim International GmbH

Isoxazoline Drugs Segment by Type

Sarolaner

Lotilaner

Fluralaner

Afoxolaner

Others

Isoxazoline Drugs Segment by Application

Dog

Cat

Others

Isoxazoline Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoxazoline Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoxazoline Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoxazoline Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isoxazoline Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Isoxazoline Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Isoxazoline Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Isoxazoline Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Isoxazoline Drugs Industry Trends Table 2. Isoxazoline Drugs Industry Drivers Table 3. Isoxazoline Drugs Industry Opportunities and Challenges Table 4. Isoxazoline Drugs Industry Restraints Table 5. Global Isoxazoline Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Isoxazoline Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Isoxazoline Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Isoxazoline Drugs Sales Market Share by Manufacturers Table 9. Global Isoxazoline Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Isoxazoline Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Isoxazoline Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Isoxazoline Drugs Manufacturers, Product Type & Application Table 13. Global Isoxazoline Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Isoxazoline Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sarolaner Table 17. Major Manufacturers of Lotilaner Table 18. Major Manufacturers of Fluralaner Table 19. Major Manufacturers of Afoxolaner Table 20. Major Manufacturers of Others Table 21. Global Isoxazoline Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Isoxazoline Drugs Sales Market Share by Type (2021-2026) Table 25. Global Isoxazoline Drugs Sales Market Share by Type (2027-2032) Table 26. Global Isoxazoline Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Isoxazoline Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Isoxazoline Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Isoxazoline Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Isoxazoline Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Dog Table 32. Major Manufacturers of Cat Table 33. Major Manufacturers of Others Table 34. Global Isoxazoline Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Isoxazoline Drugs Sales Market Share by Application (2021-2026) Table 38. Global Isoxazoline Drugs Sales Market Share by Application (2027-2032) Table 39. Global Isoxazoline Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Isoxazoline Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Isoxazoline Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Isoxazoline Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Isoxazoline Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Isoxazoline Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Isoxazoline Drugs Sales Market Share by Region (2021-2026) Table 47. Global Isoxazoline Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Isoxazoline Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Isoxazoline Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Isoxazoline Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Isoxazoline Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Isoxazoline Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Isoxazoline Drugs Revenue Market Share by Region (2027-2032) Table 66. Zoetis Inc Company Information Table 67. Zoetis Inc Business Overview Table 68. Zoetis Inc Isoxazoline Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zoetis Inc Isoxazoline Drugs Product Portfolio Table 70. Zoetis Inc Recent Development Table 71. Nissan Chemical Corporation Company Information Table 72. Nissan Chemical Corporation Business Overview Table 73. Nissan Chemical Corporation Isoxazoline Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio Table 75. Nissan Chemical Corporation Recent Development Table 76. Merck Animal Health Inc. Company Information Table 77. Merck Animal Health Inc. Business Overview Table 78. Merck Animal Health Inc. Isoxazoline Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio Table 80. Merck Animal Health Inc. Recent Development Table 81. Elanco Animal Health Incorporated Company Information Table 82. Elanco Animal Health Incorporated Business Overview Table 83. Elanco Animal Health Incorporated Isoxazoline Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio Table 85. Elanco Animal Health Incorporated Recent Development Table 86. Boehringer Ingelheim International GmbH Company Information Table 87. Boehringer Ingelheim International GmbH Business Overview Table 88. Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio Table 90. Boehringer Ingelheim International GmbH Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Isoxazoline Drugs Distributors List Table 94. Isoxazoline Drugs Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Isoxazoline Drugs Product Image Figure 2. Global Isoxazoline Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoxazoline Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Isoxazoline Drugs Sales (2021-2032) & (K Units) Figure 5. Global Isoxazoline Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Isoxazoline Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sarolaner Image Figure 9. Lotilaner Image Figure 10. Fluralaner Image Figure 11. Afoxolaner Image Figure 12. Others Image Figure 13. Global Isoxazoline Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Isoxazoline Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Isoxazoline Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Isoxazoline Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Isoxazoline Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Isoxazoline Drugs Revenue Market Share by Type (2021-2032) Figure 19. Dog Image Figure 20. Cat Image Figure 21. Others Image Figure 22. Global Isoxazoline Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Isoxazoline Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Isoxazoline Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Isoxazoline Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Isoxazoline Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Isoxazoline Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Isoxazoline Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Isoxazoline Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Isoxazoline Drugs Sales Market Share by Country (2021-2032) Figure 42. China Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Isoxazoline Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Isoxazoline Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Isoxazoline Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Isoxazoline Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Isoxazoline Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Isoxazoline Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Isoxazoline Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Sarolaner
  • Lotilaner
  • Fluralaner
  • Afoxolaner
  • Others
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Zoetis Inc
  • Nissan Chemical Corporation
  • Merck Animal Health Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Isoxazoline Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Isoxazoline Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Isoxazoline Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Isoxazoline Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Isoxazoline Drugs Market Dynamics
  1. 2.1 Isoxazoline Drugs Industry Trends
  2. 2.2 Isoxazoline Drugs Industry Drivers
  3. 2.3 Isoxazoline Drugs Industry Opportunities and Challenges
  4. 2.4 Isoxazoline Drugs Industry Restraints
3 Isoxazoline Drugs Market by Manufacturers
  1. 3.1 Global Isoxazoline Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Isoxazoline Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Isoxazoline Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Isoxazoline Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Isoxazoline Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Isoxazoline Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Isoxazoline Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Isoxazoline Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Isoxazoline Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Isoxazoline Drugs Tier 1, Tier 2, and Tier 3
4 Isoxazoline Drugs Market by Type
  1. 4.1 Isoxazoline Drugs Type Introduction
  2. 4.1.1 Sarolaner
  3. 4.1.2 Lotilaner
  4. 4.1.3 Fluralaner
  5. 4.1.4 Afoxolaner
  6. 4.1.5 Others
  7. 4.2 Global Isoxazoline Drugs Sales by Type
  8. 4.2.1 Global Isoxazoline Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Isoxazoline Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Isoxazoline Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Isoxazoline Drugs Revenue by Type
  12. 4.3.1 Global Isoxazoline Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Isoxazoline Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Isoxazoline Drugs Revenue Market Share by Type (2021-2032)
5 Isoxazoline Drugs Market by Application
  1. 5.1 Isoxazoline Drugs Application Introduction
  2. 5.1.1 Dog
  3. 5.1.2 Cat
  4. 5.1.3 Others
  5. 5.2 Global Isoxazoline Drugs Sales by Application
  6. 5.2.1 Global Isoxazoline Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isoxazoline Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Isoxazoline Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Isoxazoline Drugs Revenue by Application
  10. 5.3.1 Global Isoxazoline Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isoxazoline Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Isoxazoline Drugs Revenue Market Share by Application (2021-2032)
6 Global Isoxazoline Drugs Sales by Region
  1. 6.1 Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isoxazoline Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Isoxazoline Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Isoxazoline Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Isoxazoline Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Isoxazoline Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Isoxazoline Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Isoxazoline Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Isoxazoline Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Isoxazoline Drugs Revenue by Region
  1. 7.1 Global Isoxazoline Drugs Revenue by Region
  2. 7.1.1 Global Isoxazoline Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Isoxazoline Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Isoxazoline Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Isoxazoline Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Isoxazoline Drugs Revenue (2021-2032)
  8. 7.2.2 North America Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Isoxazoline Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Isoxazoline Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Isoxazoline Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Isoxazoline Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis Inc
  2. 8.1.1 Zoetis Inc Company Information
  3. 8.1.2 Zoetis Inc Business Overview
  4. 8.1.3 Zoetis Inc Isoxazoline Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Inc Isoxazoline Drugs Product Portfolio
  6. 8.1.5 Zoetis Inc Recent Developments
  7. 8.2 Nissan Chemical Corporation
  8. 8.2.1 Nissan Chemical Corporation Company Information
  9. 8.2.2 Nissan Chemical Corporation Business Overview
  10. 8.2.3 Nissan Chemical Corporation Isoxazoline Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio
  12. 8.2.5 Nissan Chemical Corporation Recent Developments
  13. 8.3 Merck Animal Health Inc.
  14. 8.3.1 Merck Animal Health Inc. Company Information
  15. 8.3.2 Merck Animal Health Inc. Business Overview
  16. 8.3.3 Merck Animal Health Inc. Isoxazoline Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio
  18. 8.3.5 Merck Animal Health Inc. Recent Developments
  19. 8.4 Elanco Animal Health Incorporated
  20. 8.4.1 Elanco Animal Health Incorporated Company Information
  21. 8.4.2 Elanco Animal Health Incorporated Business Overview
  22. 8.4.3 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio
  24. 8.4.5 Elanco Animal Health Incorporated Recent Developments
  25. 8.5 Boehringer Ingelheim International GmbH
  26. 8.5.1 Boehringer Ingelheim International GmbH Company Information
  27. 8.5.2 Boehringer Ingelheim International GmbH Business Overview
  28. 8.5.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio
  30. 8.5.5 Boehringer Ingelheim International GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isoxazoline Drugs Value Chain Analysis
  2. 9.1.1 Isoxazoline Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isoxazoline Drugs Production Mode & Process
  6. 9.2 Isoxazoline Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isoxazoline Drugs Distributors
  9. 9.2.3 Isoxazoline Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst